OpenAI Pushes IPO Beyond 2026, Chilling the Private AI Market

OpenAI won't go public until at least 2027, resetting market timelines and pressuring competitors like Anthropic amid rising AI safety concerns.

Jurgen Goldmeier ·

OpenAI Pushes IPO Beyond 2026, Chilling the Private AI Market

OpenAI Pushes IPO Beyond 2026, Chilling the Private AI Market OpenAI will not pursue an initial public offering before 2027, CEO Sam Altman stated in a Fortune interview released Saturday. His explicit timeline, pushing a public listing well past current market expectations, signals a significant repricing for the most anticipated technology debut in years and cools the entire private AI sector. ## Background The market has been positioned for a series of blockbuster IPOs from leading artificial intelligence firms, with OpenAI and its rival Anthropic expected to command massive valuations. These offerings were seen as the primary catalysts to fully reopen the IPO window for high-growth, cash-burning technology companies. Investors in late-stage venture funds have been banking on these exits to provide liquidity and validate the multi-billion dollar paper valuations assigned to top AI “unicorns”—private companies valued at over $1 billion. Altman’s move comes amid a sharp increase in public debate over AI safety. The narrative gained momentum after a former Anthropic safety researcher resigned with a public warning about the industry’s trajectory. This puts the current discourse on AI risk in direct conflict with the aggressive growth story required to sell a large-scale IPO to public investors. It also complicates the position of Anthropic, whose own CEO has called for a development slowdown even as it was presumed to be on a path to the public markets. ## Why it matters By taking a 2026 IPO off the table, Altman removes the single biggest catalyst from the near-term tech calendar. This forces a timeline reassessment for any fund holding illiquid, high-priced private OpenAI shares. The delay reads through directly to Anthropic and other richly valued AI firms. The market must now price in a new, ambiguous risk factor tied to “safety,” which is difficult for financial models to quantify and could invite regulatory scrutiny. Those on the wrong side of this are the crossover funds and late-stage investors who paid premium valuations for private shares expecting a 2025 or 2026 exit. They now face a longer holding period with an uncertain outcome. The ball is now in Anthropic CEO Dario Amodei’s court. His firm must decide whether to follow OpenAI’s cautious posture or attempt to brave the public markets while its own leadership publicly preaches restraint—a difficult message to deliver on an IPO roadshow. ## What to watch The market will now focus on Anthropic for any signal on its own public market ambitions. Any formal statement or interview from its executive team regarding IPO timing will be a critical tell for whether OpenAI’s delay is company-specific or the start of a sector-wide trend. A surprise S-1 filing from another major AI player would indicate that investor appetite for growth can overpower the safety narrative. Conversely, if Anthropic also signals a delay or if the next major AI funding round is completed at a flat or down valuation, it would confirm a broader cooling. By the end of August, the market should have a clearer picture of whether the AI IPO pipeline is frozen or merely rerouted.

More stories